World's Best Scientists 2026 revealed!
Laurence Boumsell

Laurence Boumsell

D-Index & Metrics

Immunology

D-Index
63
Citations
11694
World Ranking
3068
National Ranking
132

Laurence Boumsell publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Laurence Boumsell sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 201 publications — 35th percentile

35% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Laurence Boumsell D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Laurence Boumsell sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 63 D-Index — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Laurence Boumsell is affiliated with Inserm in France, a prominent institution known for its focus on biomedical research. Their work is situated within a research environment that emphasizes advanced studies in health and medical sciences.

Although specific details about recent papers are not available, it is clear that Laurence Boumsell contributes to ongoing research activities within their institution. Inserm, as a research organization, typically supports a wide range of projects in areas such as immunology, oncology, and molecular biology, indicating potential areas of engagement.

Information about frequent co-authors or collaborations is not listed, suggesting that either Laurence Boumsell works independently or the data on collaborative efforts has not been recorded. Similarly, no specific frequent publication venues are identified, which might imply publications in diverse journals or yet unrecorded venues.

There are no records of book publications, which points to a research focus primarily concentrated on articles and studies rather than extended monographic works.

Data on main fields of study, subfields, and main research topics for Laurence Boumsell are not provided. This limits the ability to define precise thematic areas of expertise or specialization. Likewise, no awards or honors have been noted, which reflects only on the available documentation rather than the full scope of the scientist's career.

Laurence Boumsell is currently active and not deceased, indicating ongoing potential contributions to their field. The absence of detailed public-facing information underscores a profile that is either early-career, highly specialized, or one whose detailed academic footprint is not yet broadly disseminated in open databases.

Best Publications

  • Toxic epidermal necrolysis: Effector cells are drug-specific cytotoxic T cells

    Amal Nassif;Armand Bensussan;Laurence Boumsell;Aurelien Deniaud

  • Drug Specific Cytotoxic T-Cells in the Skin Lesions of a Patient with Toxic Epidermal Necrolysis

    Amal Nassif;Armand Bensussan;Guillaume Dorothée;Fathia Mami-Chouaib

  • Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation.

    Kathryn T. Hall;Laurence Boumsell;Joachim L. Schultze;Vassiliki A. Boussiotis

  • Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma

    Alain Bernard;Alain Bernard;Laurence Boumsell;Laurence Boumsell;Ellis L. Reinherz;Ellis L. Reinherz;Lee M. Nadler;Lee M. Nadler

  • CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival

    Silvia Deaglio;Tiziana Vaisitti;Luciana Bergui;Lisa Bonello

  • Evidence that granulocyte macrophage-colony-stimulating factor regulates the distribution and differentiated state of dendritic cells/Langerhans cells in human lung and lung cancers.

    A Tazi;F Bouchonnet;M Grandsaigne;L Boumsell

  • Evaluation of the potential role of cytokines in toxic epidermal necrolysis.

    Amal Nassif;Homayoun Moslehi;Homayoun Moslehi;Sabine Le Gouvello;Martine Bagot

  • AN ANTIGEN SHARED BY A HUMAN T CELL SUBSET AND B CELL CHRONIC LYMPHOCYTIC LEUKEMIC CELLS Distribution on Normal and Malignant Lymphoid Cells

    L Boumsell;H Coppin;D Pham;B Raynal

  • Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury

    Li Zhu;Wolfgang Bergmeier;Jie Wu;Hong Jiang

  • CD molecules 2006 — Human cell differentiation molecules

    Heddy Zola;Bernadette Swart;Alison Banham;Simon Barry

  • CD158k/KIR3DL2 is a new phenotypic marker of Sezary cells: relevance for the diagnosis and follow-up of Sezary syndrome.

    Ewa Poszepczynska-Guigné;Valérie Schiavon;Michel D'Incan;Hamid Echchakir

  • Isolation of tumor-specific cytotoxic CD4+ and CD4+CD8dim+ T-cell clones infiltrating a cutaneous T-cell lymphoma

    Martine Bagot;Hamid Echchakir;Hamid Echchakir;Fathia Mami-Chouaib;Fathia Mami-Chouaib;Marie-Hélène Delfau-Larue;Marie-Hélène Delfau-Larue

  • Biological Activity of Soluble CD100. II. Soluble CD100, Similarly to H-SemaIII, Inhibits Immune Cell Migration

    Stéphanie Delaire;Christian Billard;Rafaèle Tordjman;Alain Chédotal

  • T cell activation via CD2 [T, gp50] molecules: accessory cells are required to trigger T cell activation via CD2-D66 plus CD2-9.6/T11(1) epitopes.

    P Brottier;L Boumsell;C Gelin;A Bernard

  • Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytes

    Anukanth Anumanthan;Armand Bensussan;Laurence Boumsell;Andreas D. Christ

  • Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity

    Philippe Le Bouteiller;Aliz Barakonyi;Jérome Giustiniani;Françoise Lenfant

  • CD molecules 2005: human cell differentiation molecules

    Heddy Zola;Bernadette Swart;Ian Nicholson;Bent Aasted

  • Increased surface expression of a newly identified 150-kDa dimer early after human T lymphocyte activation.

    C. Bougeret;Indra Gusti Mansur;H. Dastot;M. Schmid

  • Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors

    L Le Cleach;S Delaire;L Boumsell;M Bagot

  • Some chronic lymphocytic leukemia cells bearing surface immunoglobulins share determinants with T cells

    Laurence Boumsell;A. Bernard;Virginia Lepage;L. Degos

  • CD4+ cutaneous T-cell lymphoma cells express the p140–killer cell immunoglobulin-like receptor

    Martine Bagot;Alessandro Moretta;Alessandro Moretta;Simona Sivori;Simona Sivori;Roberto Biassoni;Roberto Biassoni

Frequent Co-Authors

Armand Bensussan
Armand Bensussan Hôpital Saint-Louis
Alain Bernard
Alain Bernard Grenoble Alpes University
Jean Dausset
Jean Dausset Grenoble Alpes University
Jerome Ritz
Jerome Ritz Harvard University
Stuart F. Schlossman
Stuart F. Schlossman Harvard University
Georges Bismuth
Georges Bismuth Université Paris Cité
Martine Bagot
Martine Bagot Université Paris Cité
Lee M. Nadler
Lee M. Nadler Harvard University
Fathia Mami-Chouaib
Fathia Mami-Chouaib Institut Gustave Roussy
Timothy A. Springer
Timothy A. Springer Boston Children's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology and healthcare, pursuing related nursing degrees can open diverse career opportunities. Many professionals start with an accelerated nursing program to gain essential clinical skills quickly. Programs like 12-month accelerated nursing programs online for non nurses enable individuals without a nursing background to transition efficiently into the field.

Once you have a BSN, advancing to specialized roles is common. Accelerated pathways such as accelerated bsn programs for non nurses provide streamlined access for career changers. For those aiming to become nurse practitioners with a focus on acute care, a fnp to acute care np bridge program offers a tailored curriculum to meet this demand.

Moreover, pursuing an accelerated nurse practitioner program can significantly shorten the time to enter advanced practice roles. These pathways are ideal for motivated students who want to integrate Immunology knowledge with clinical expertise and impact patient care on a deeper level.

Best Scientists Citing Laurence Boumsell

Recently Published Articles